The expression of the fusion protein is controlled by the TENM4 promoter, and it has been shown to induce breast cancer cell proliferation [123] through the constitutive activation of the ErbB3–ErbB2 complex via Υ-heregulin-dependent autocrine stimulation [123,124]. This evidence concerns the gene NRG1 and breast cancer.